Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002514098 | SCV003441424 | likely pathogenic | Multiple endocrine neoplasia, type 2 | 2022-08-20 | criteria provided, single submitter | clinical testing | This missense change has been observed in individual(s) with Hirschsprung disease (PMID: 7581377, 8114939). It has also been observed to segregate with disease in related individuals. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change affects RET function (PMID: 8654369, 8894691, 9681515, 20473317). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 13923). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 32 of the RET protein (p.Ser32Leu). |
OMIM | RCV000014948 | SCV000035204 | risk factor | Hirschsprung disease, susceptibility to, 1 | 1994-01-27 | no assertion criteria provided | literature only | |
Clinical Molecular Genetics Laboratory, |
RCV000678742 | SCV000804914 | likely pathogenic | Aganglionic megacolon | 2014-07-29 | no assertion criteria provided | clinical testing |